Authors: Cong TH, Wei Y, Zhao ZL, Cao SL, Yu N, Wu J, Zhou XY, Zhao HX, Peng LL, Li Y, Yu MA.
DOI: 10.3389/fendo.2025.1736498
Abstract Summary
Thermal ablation shows promise for intermediate-risk papillary thyroid cancer, achieving 100% complete ablation with 79.8% recurrence-free survival at 5 years. In 113 patients, lymph node size emerged as a key predictor of progression, suggesting this minimally invasive approach could benefit carefully selected cases.
Why Brain? ðŸ§
Thermal ablation shows 100% success treating intermediate-risk thyroid cancer with 79.8% recurrence-free survival at 5 years. Lymph node size predicts outcomes, offering surgery alternative.
License: CC BY.
The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.
